TOKYO and SHANGHAI, Feb. 5, 2026 -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Shanghai Henlius Biotech, Inc. (Headquarters: Shanghai, China, CEO: Jason Zhu, "Henlius") announced today the conclusion of an exclusive commercialization and co-exclusive development and manufacturing license agreement for the anti-PD-1 antibody serplulimab (generic name, marketed as HANSIZHUANG in China and Hetronifly® in the EU) in Japan. Serplulimab, a novel anti-PD-1 monoclonal antibody developed by Henlius, is reported to possess a unique binding mode t
SINGAPORE, Feb. 5, 2026 -- Dyna.Ai, a global provider of AI solutions, today released a new executive insights report, developed in collaboration with GXS Partners and Smartkarma, examining why most banks struggle to translate AI investment into revenue, and how a small group is breaking through. The report highlights how financial institutions across Southeast Asia, Latin America, and the Middle East are unlocking revenue through a small number of AI capabilities, while emphasizing the operational conditions required to scale these in production. The research finds that banks successf
SHANGHAI, Feb. 5, 2026 -- Insight Lifetech, a portfolio company of Qiming Venture Partners and a leading Chinese innovative medical device manfaucturer, successfully listed on the Shanghai Stock Exchange's STAR Market on February 5, 2026 Beijing time. Insight Lifetech (688712.SH) issued shares at a price of CNY17.52 per share and opened at CNY50.31 per share with a market capitalization of CNY20.98 billion. Qiming Venture Partners led the C round financing of Insight Lifetech in 2020 and continued to fund the company's development in the D round. Before the company's IPO, Qiming Ventur
[ 메디채널 황정호 기자 ] Strategic Combination Provides Asset Managers, Fund Administrators and Transfer Agents with an Integrated solution to support Exchange-Traded Funds LUXEMBOURG, Feb. 5, 2026 -- Multifonds, a leading global provider of fund administration software and SaaS solutions and Ultumus, a SIX Group company specialising in ETF infrastructure technology, today announced a strategic partnership designed to enable fund providers to rapidly expand into the fast-growing ETF market. The collaboration gives Multifonds' clients direct access to Ultumus' specialised ETF te
[ 메디채널 김갑성 기자 ] Sustained execution and high-impact data across HanchorBio's next-generation immuno-oncology portfolio to be featured at ASCO-GI, AACR-IO, ESMO-TAT, ICNHO, and WOC TAIPEI and SHANGHAI and SAN FRANCISCO, Feb. 4, 2026 -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company pioneering transformative immunotherapies, today announced a robust schedule of scientific presentations at major international oncology congresses throughout Q1 2026. The selection of multiple abstracts, including four high-profile oral presentations, underscores the clinical
SHANGHAI, Feb. 5, 2026 -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE: DDL), a leading fresh grocery e-commerce company in China, today announced that it has entered into a definitive Share Purchase Agreement (the "Share Purchase Agreement") with Two Hearts Investments Limited ("Buyer"), a wholly-owned subsidiary of Meituan (HKEX: 3690). Pursuant to the Share Purchase Agreement, Dingdong has agreed to sell to the Buyer all issued and outstanding shares of Dingdong Fresh Holding Limited, Dingdong's wholly-owned subsidiary incorpo
HONG KONG, Feb. 5, 2026 -- ATFX is proud to announce that its Global Head of Marketing, Ms. Weems Chan, has been honoured with the esteemed "Hong Kong's Woman Leaders" Award by the World Women Leadership Congress (WWLC). The award recognises leaders who make a real impact by guiding diverse teams and managing complex projects across different markets. A Collective Achievement and Leadership Philosophy The recognition reflects Ms. Chan's leadership journey and her contributions to ATFX and the wider business community. Reflecting on the honour, Ms. Chan described the aw
LUXEMBOURG, Feb. 5, 2026 -- Frontier Rare Earths Limited ("Frontier" or the "Company"), which is developing the Zandkopsdrift magnet rare earths and battery grade manganese project in South Africa, is pleased to announce the signing of a Technology Supply Agreement with Carester SAS ("Carester"), one of the leading western rare earths separation specialists, and an investment of US$20m from South Africa's Industrial Development Corporation to finance a Definitive Feasibility Study ("DFS"), with first production targeted for 2030.
SYDNEY, Feb. 5, 2026 -- Amid heightened volatility in global precious metals markets, VT Markets has proven the strength of its trading infrastructure, maintaining stable execution and uninterrupted access during periods of intense market stress. During the recent market volatility, VT Markets recorded USD1.5 trillion in gold trading volume in January, underscoring strong client engagement and sustained confidence in its trading environment. Notably, 20% of gold traders were new to the platform, highlighting VT Markets' ability to attract new traders eager to seize opportunitie
[ 메디채널 황정호 기자 ] Deliver enhanced wealth-planning capabilities and client experience for HNW individuals HONG KONG, Feb. 5, 2026 -- AXA Hong Kong and Macau ("AXA") is pleased to announce its strategic initiative with Deloitte Private, to elevate its wealth management offerings for high-net-worth (HNW) clients and drive sustainable growth in this premium segment. This initiative brings together AXA's extensive expertise in insurance solutions with Deloitte Private's renowned capabilities in tax planning and wealth advisory, creating a powerful synergy designed to meet the evo